Your session is about to expire
← Back to Search
Internal Brace vs LRTI for Thumb Osteoarthritis
Study Summary
This trial is testing whether a new treatment for carpal metacarpal osteoarthritis (CMC OA) is better than the current standard of care. The new treatment is called internal brace (IB), and it is being compared to the current standard, which is called ligament reconstruction and tendon interposition (LRTI). The trial will test whether IB is more effective than LRTI in terms of patient-reported outcomes, objective clinical outcomes, and return to work/activity.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have arthritis that only affects the joint at the base of your thumb.You have rheumatoid arthritis or another type of inflammatory arthritis at the same time.You are having surgery to fix hyperextension of your thumb's metacarpophalangeal joint.You have been taking opioids for a long time.You do not have carpal tunnel syndrome to avoid confusion in the study results.
- Group 1: LRTI
- Group 2: Internal Brace
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacant spots for potential participants in this investigation?
"According to clinicaltrials.gov, this medical experiment is not enrolling any more patients at the present time. Posted on January 1 2020 and last edited April 26 2022, it has since been superseded by 613 other trials that are actively accepting participants."
What are the chief goals of this investigation?
"The duration of this medical trial is around 12 months and its primary outcome is the randomization rate. Secondary objectives include assessing thumb range of motion at specific joints, collecting PROMIS Upper Extremity and Physical Function scores via iPad devices, as well as measuring pinch strength with a gauge and grip strength using dynamometer. All results are normalized to mean score 50 standard deviations 10 in order to counteract floor or ceiling effects while making sure that data remains comprehensible. Higher values on all PROMIS CATs indicate greater levels of the domain measured; for instance higher Physical Function scores imply better functioning overall. The two aforementioned outcomes will be reported separately rather"
Share this study with friends
Copy Link
Messenger